Deciphera Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of DCPH for the last quarter is 48.30 M USD, and it's 11.50% higher compared to the previous quarter. The net income of Q4 23 is -47.19 M USD.